Immune-mediated Mucocutaneous Disease 1 Flashcards

1
Q

Which of these mucocutaneous lesions is immune-mediated?

  • ectodermal dysplasia
  • white sponge nevus
  • lichen planus
  • Peutz-Jeghers
A

lichen planus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True or False: With pemphigus vulgaris, the autoantibodies destroy hemidesmosomes.

A

False, AB destroy desmosomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

True or False: Pemphigus vulgaris has no sex predilection.

A

True, PV…pemphigus vulgaris…PV…penis or vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pemphigus Vulgaris is a rare immune mediated condition that is _____ if not treated.

A

fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is PV fatal when not treated?

A

SEVERE INFECTION:

  • loss of fluids
  • malnutrition due to mouth pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How often do PV patients present with oral lesions? What do oral lesions look like?

A

50%
superficial, ragged erosions and ulcerations
any mucosal surface
oral blisters seen rarely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PV lesions on the skin appear as _______ _____.

A

flaccid bullae

nikolsky sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the presentation of a positive Nikolsky sign.

A

apply firm, lateral pressure to normal appearing skin

= induces a bulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

True or False: The skin bullae with PV are the “first to show and last to go”

A

False, the oral lesions are first

oral: initial manifestation and most difficult to resolve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is immunofluorescence and its sub-categories?

A

a technique that uses fluorescent-labeled antibodies to detect specific targets

  • DIF (direct)
  • IFF (indirect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Direct Immunofluorescence used for?

A

to detect autoantibodies bound to the patient’s tissues

fluoro-IgG + patient biopsy–> microscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Indirect Immunofluorescence used for?

A

to detect antibodies circulating in the blood

patient serum + control tissue + fluoro-IgG–> microscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

True or False: Both direct and indirect immunofluorescence will be negative in pemphigus vulgaris.

A

False, both DIF and IFF are positive in PV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Normal tissue adjacent to PV ulceration should be sampled for _____.

A

DIF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Autoantibodies in PV will bind to ______ components.

A

desmosomal (desmoglein 1 & desmoglein 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where should the PV sample be obtained for biopsy?

A

Lesions of PV should be sampled at the periphery, no the ulcerated center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the microscopic feature that is always present with PV? What is the feature that is usually present?

A

always: intraepithelial clefting above the basal layer (within the epithelium)
often: acantholysis (breakdown of spinous layer, cells appear to fall apart)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is Pemphigus Vulgaris treated?

A
  • systemic corticosteroids: often azathioprine or other steroid-sparing agents
  • topical corticosteroids have little effect*
19
Q

True or False: PV is treated with either systemic or topical corticosteroids, whichever they prefer to use.

A

False, only systemic will work

20
Q

What is the mortality rate of PV? What was the rate prior to corticosteroid therapy?

A

5-10% mortality (complications of therapy)

60-90% mortality (prior to meds)

21
Q

Which immune-mediated mucocutaneous lesion has a similar clinical presentation to PV but is more than 2 times as common?

A

Mucous Membrane Pemphigoid

22
Q

Mucous Membrane Pemphigoid is also known as _______ pemphigoid, which means “scarring.”

A

cicatricial

23
Q

MMP has a ______ predilection with an average age of _____ years.

A

female (2:1)

50-60

24
Q

True or False: MMP may affect any mucosal surface and occasionally the skin.

A

True

25
Q

Why is MMP also refered to as Cicatricial Pemphigoid?

A

scarring is usually seen with conjunctival and cutaneous lesions
(intraoral = rare scarring, may see intact blisters)

26
Q

Mucous Membrane Pemphigoid often presents as _______ gingivitis. What does this mean?

A

“desquamative gingivitis”

  • erythema, desquamation, ulceration
  • seen with several disorders, not just MMP
27
Q

What is the most significant aspect of MMP?

A

ocular involvement

  • scarring obstructs the orifices of glands that produce the tear film, resulting in dry eye
  • dryness leads to keratinization of the corneal epithelium, leading to blindness
28
Q

For histological purposes, where should the sample of MMP be taken from?

A

periphery of the lesion, including a generous portion of normal mucosa (epithelium shears off easily)

29
Q

What are the microscopic characteristics of MMP?

A

SUBepithelial cleft formation- separation of the epithelium from the connective tissue at the basement membrane

  • MMP: between epithelium and CT
  • PV: within epithelium
30
Q

Antibodies in PV will attack the _______; Antibodies in MMP will attack the ______.

A

PV= desmosomes
MMP= hemidesmosomes
(3 letters = longer word; 2 letters = shorter word)

31
Q

Oral mucosa submitted for MMP testing should be taken from _______cm away from the areas of ulceration. Tissue should, ideally, be submitted in both ______ solution and _____ solution.

A

0.5-1.0 cm
Michel’s
formalin

32
Q

Linear deposition of immunoreactants at the BMZ, with a positive DIF and a negative IFF would indicate that the patient has _____.

A

mucous membrane pemphigoid

PV: both DIF and IFF are positve
(MMP: only DIF is positive)

33
Q

What percentage of patients will have circulating autoantibodies against hemidesmosomes (MMP)?

A

5-25% of MMP patients will have circulating antibodies (which is why IFF is negative)

34
Q

How is MMPemphigoid treated?

A

Depends on extent of involvement:

  • frequent prophylaxis every 3-4 mos
  • oral lesions only = topical steroids, tetracycline/niacinamide or dapsone may be sufficient)
  • ocular involvement = systemic immunosuppressive therapy

remember, PV = systemic only! topical has no effect

35
Q

What is the prognosis of MMP?

A

rarely fatal, condition is usually controlled

  • blindness if ocular disease is left untreated
  • rarely resolves spontaneously
36
Q

True or False: Bullous pemphigoid usually affects a younger population.

A

False, older

37
Q

What is the most common initial complaint of bullous pemphigoid? Second most common initial complaint?

A
  1. pruritus

2. cutaneous blisters

38
Q

Which type of lesions are seen most commonly with bullous pemphigoid?

A

cutaneous

*oral is uncommon: 8-39%

39
Q

How often are oral lesions found with bullous pemphigoid?

A

8-39%

40
Q

True or False: BP Clefting of the epithelium is intraepithelial.

A

False, BP is suBBBBepithelial (like MMP)

41
Q

True or False: Both DIF and IFF are positive for bullous pemphigoid.

A

True

42
Q

True or False: Most BP cases resolve spontaneously.

A

True, most within 1-2 years

management is similar to MMP

43
Q

Erythema Multiforme is an ulcerative disorder that has _____ onset and is self-limiting within _____ weeks.

A

acute

2-6 weeks

44
Q

Erythema Multiforme is more likely to affect which of the following:

  • 20 year old male
  • 20 year old female
  • 50 year old male
  • 50 year old female
A

20 year old female

(as of recently. Used to believe that it affected males more, but it is probably immune-mediated so it makes sense that females are more likely)